ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Miami, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Miami, FL, USA:

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...

Active, not recruiting
Breast Cancer
Procedure: Surgical resection of breast tumor
Drug: ARV-471

Phase 2

Arvinas
Arvinas

Fort Lauderdale, Florida, United States and 48 other locations

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy [paclitaxel] and ave ...

Active, not recruiting
Breast Cancer Metastatic
Biological: Pelareorep
Drug: Paclitaxel

Phase 2

Oncolytics Biotech

Miami, Florida, United States and 17 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Hollywood, Florida, United States and 57 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Miami, Florida, United States and 114 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

Plantation, Florida, United States and 324 other locations

human epidermal receptor 2-negative (HER2)- palbociclib-resistant breast cancer, and to determine the recommended Phase 2 dose (RP2...

Active, not recruiting
Breast Cancer
Drug: ribociclib
Drug: TTI-101

Phase 1, Phase 2

Tvardi Therapeutics

Fort Lauderdale, Florida, United States and 5 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Miami, Florida, United States and 50 other locations

Status recently updated

The purpose of this study is to compare the effect of Eflapegrastim on duration of neutropenia in patients with early-stage breast cancer...

Enrolling
Active, not recruiting
Breast Cancer
Neutropenia
Drug: Docetaxel
Biological: Eflapegrastim

Phase 1

Spectrum Pharmaceuticals
Spectrum Pharmaceuticals

Plantation, Florida, United States of America and 7 other locations

Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...

Enrolling
Breast Cancer
Breast Carcinoma in Situ
Device: Provide a saliva sample for genetic testing
Other: Screening advice based on a basic risk assessment
University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

Miami, Florida, United States and 10 other locations

The purpose of this study is to evaluate the safety and tolerability of talectrectinib as treatment for Stage IV ILC with CDH1 mutation

Begins enrollment in 4 months
Breast Cancer
Metastatic Breast Cancer
Drug: Taletrectinib

Phase 2

Megan Kruse, MD

Weston, Florida, United States and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems